Study of a new medicine to ease cannabis withdrawal
Treatments studied
Part of Mental health clinical trials.
This study tests a new medicine, PP-01, to help adults who use cannabis daily and want to quit. It aims to reduce withdrawal symptoms like anxiety, irritability, and sleep problems during the first week after stopping.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You use cannabis daily or almost daily and want to stop.
- You are willing to stay in a clinic for 6 nights and attend weekly visits.
- You agree to stop using cannabis and all related products during the study.
- You are generally healthy and have a body mass index (BMI) between 18 and 38.
- You are willing to use birth control if you or your partner can have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two cannabis-like medicines, dronabinol and Epidiolex, can help reduce withdrawal symptoms and other discomforts people may feel when they first start taking buprenorphine for opioid use disorder. If you've recently started buprenorphine and still have symptoms, this study might offer extra relief.
This study tests whether cannabis can help ease opioid withdrawal and reduce opioid use. Participants will stay at the hospital for about 6 weeks to receive the study treatment and be closely monitored.
This study looks at whether different types of cannabis (containing THC and/or CBD) might help people who use cannabis regularly reduce potential harms. You will be asked to take cannabis in a controlled setting and complete tasks and questionnaires.
This study tests whether tirzepatide, a medicine used for diabetes and weight loss, can help reduce cannabis use in people with moderate to severe cannabis use disorder. If you qualify, you would take the medicine for a period and track your cannabis use.
This early (Phase 1) study tests how an oral THC and CBD product affects the body in healthy adults who use cannabis only rarely. It may help researchers understand safety and effects before larger studies.
This study tests whether cannabidiol (CBD) can help young adults who use cannabis heavily but aren't looking to quit. You'll take a CBD pill and see if it changes your cannabis use or related symptoms.
Hear when a new Cannabis Withdrawal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.